Jeena Sikho Lifecare's EPS (Basic) for the
three
months ended in Mar. 2026 was ₹3.63.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹17.85.
During the past 12 months, Jeena Sikho Lifecare's average EPS without NRIGrowth Rate was 177.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 83.30% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 87.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 8 years, Jeena Sikho Lifecare's highest 3-Year average EPS without NRI Growth Rate was 95.70% per year. The lowest was 21.10% per year. And the median was 84.40% per year.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Jeena Sikho Lifecare EPS (Diluted) Related Terms
Jeena Sikho Lifecare EPS (Diluted) Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JSLL vs HCA, THC, DVA: EPS (Diluted) Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's PE Ratio distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Jeena Sikho Lifecare's Diluted EPS for the fiscal year that ended in Mar. 2026 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹17.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeena Sikho Lifecare (NSE:JSLL) has a EPS (Diluted) of ₹17.81 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Jeena Sikho Lifecare and its competitors.
Is Jeena Sikho Lifecare's EPS (Diluted) too high?
Jeena Sikho Lifecare's current EPS (Diluted) is ₹17.81. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's EPS (Diluted) compare to HCA and THC?
Jeena Sikho Lifecare's EPS (Diluted) of ₹17.81 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Healthcare Providers & Services company?
A good EPS (Diluted) depends on the Healthcare Providers & Services industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Jeena Sikho Lifecare and its competitors. Jeena Sikho Lifecare's current EPS (Diluted) is ₹17.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.54, compared to a current price of ₹602.25 — trading 21.9% below its estimated fair value. The current EPS (Diluted) is ₹17.81. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current EPS (Diluted) is ₹17.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹602.25 is trading 21.9% below its estimated GF Value™ of ₹771.54.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
EPS (Diluted): ₹17.81
GF Value™: ₹771.54 vs. price of ₹602.25 (21.9% below fair value)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score
Get the complete analysis for NSE:JSLL
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
